Business Finland launches a new program in the area of health, focused on creating new international business and innovations for personalized healthcare platforms, and on attracting foreign investment to Finland.
Nordic Life Science
The latest business news
The capital of Sweden possesses not only world-renowned academic research and high profile life science companies, it is also home to many of the country’s most important national life science efforts and leading centers. The
Follicum announces that all patients in the Phase IIa clinical trial with FOL-005 for stimulating hair growth have been recruited. The trial is conducted at the Clinical Research Center for
Our region is filled with life science activity. We take a closer look at what´s going in our Nordic cities when it comes to life science efforts, progress and challenges.
Nordic Life Science
The latest clinical trials
Following a planned review, the Data Monitoring Committee (DMC) has recommended that the Phase Ib/II study (CALLISTO/LUC2001) of daratumumab in combination with atezolizumab versus atezolizumab monotherapy in patients with previously
The results from the Phase III study of Arzerra (ofatumumab) plus bendamustine did not meet the primary endpoint of improved progression-free survival (PFS) in patients with indolent B-cell non-Hodgkin’s lymphoma
AstraZeneca and MedImmune has announced positive overall survival (OS) results for the Phase III PACIFIC trial, a randomised, double-blinded, placebo-controlled, multi-centre trial of Imfinzi (durvalumab) in patients with unresectable Stage III non-small
BioInvent International has received authorization to proceed from the Swedish Medical Product Agency for a new clinical trial that will study the activity of its proprietary monoclonal antibody BI-1206. The
The company starts the clinical development of a potential new treatment of schizophrenia and Alzheimer’s disease and divests two research programs to biotech company MindImmune Therapeutics. A phase I-study in
The company has been chosen as sole supplier to a screening project for atrial fibrillation in Great Britain. The project is the largest longterm screening project with the aim to
The company announces results from its phase I/II trial of ONCOS-102 in mesothelioma, in combination with standard of care chemotherapy, in which clinical responses were observed in three out of
AstraZeneca and MedImmune announce results from their Phase III ARCTIC trial in patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least two prior treatments.
The company provides an update on its clinical development programme, including updated guidance on expected milestones for the pivotal PARADIGME trial, and its financial outlook. A re-assessment of expected recruitment
The latest research findings from the Nordic region
This year’s Wallenberg Clinical Scholars conduct clinical research in order to discover markers that can reveal dementia and Parkinson’s disease at an early stage, to develop better treatments for the
Scientist from Uppsala University has discovered a specific host protein that many viruses use for their transport within the cell. With modern DNA sequencing technologies it is relatively easy to
Asthma and high blood pressure drugs influence risk of developing parkinson’s disease. Outwardly, Parkinson’s disease (PD) appears as tremors and stiffness. In the brain, neurons fill with aggregates of α-synuclein
Professor Vessela Kristensen is awarded King Olav V’s Prize for Cancer Research for her research on breast cancer. Kristensen is a Professor at the University of Oslo, and associated to
The Maersk Tower is a research building whose architecture creates a framework for health research. It aims to contribute positively by linking the University of Copenhagen with the surrounding neighbourhoods
The University of Helsinki has recruited Professor Mark Daly of the Broad Institute of MIT and Harvard and Massachusetts General Hospital to lead the Institute for Molecular Medicine Finland (FIMM).